Development and in vivo evaluation of novel monolithic controlled release compositions of galantamine hydrobromide as against reservoir technology

References

• Chien YW. Novel drug delivery systems. New York: Marcel Dekker, 1992; 139–196.
   Google Scholar
• Vyas SP, Khar RK. Controlled drug delivery: Concepts and advances. India: Vallabh Prakashan, 2002:155–195.
   Google Scholar
• Shaikh NA, Block LH, Abidi SE. Evaluation of ethylcellulose as a matrix for prolonged release formulations. II. Sparingly water-soluble drugs: ibuprofen and indomethacin. Drug Dev Ind Pharm 1987; 13:2495–2518.
   Web of Science ®Google Scholar
• Pather SI, Russel I, Syce JA, Neau SH. Sustained release theophylline tablets by direct compression. Part 1: formulation and in vitro testing. Int J Pharm 1998; 164:1–10.
   Web of Science ®Google Scholar
• Aoki S, Ohwaki T, Uesugi K, Tatsuishi K, Ozawa H, Kayano M. Preparation of novel type of controlled-release carrier and evaluation of drug release from the matrix tablet and its physical properties. Int J Pharm 1992; 85:29–38.
   Google Scholar
• Boles MG, Deasy PB, Donnellan MF. Microencapsulation studies on aminophylline involving spherical crystallization, spheronization and drug loading on to non-pareil seeds. J Microencapsul 1994;11:55–67.
   PubMed Web of Science ®Google Scholar
• Takei N, Unosawa K, Matsumoto S. Preparation of Controlled Release Particles by Suspension Spray Method Using Fluidized Bed Coater with Rotary Disk. J Soc Powder Technol 1999; 36:98–105.
   Google Scholar
• Tang L, Wigent RJ, Schwartz JB. Drug release from film-coated chlorpheniramine maleate nonpareil beads: water influx and development of a new drug release model. Pharm Dev Technol 1999;4:481–490.
   PubMed Web of Science ®Google Scholar
• Parojcic Jelena Duric, Zorica, Jovanovic Millica Ibric, Svetlana. An Investigation into the Factors Influencing Drug Release from Hydrophilic Matrix Tablets Based on Novel Carbomer Polymers. Drug Del 2004; 11:59–65.
   PubMed Web of Science ®Google Scholar
• Nahla S Barakat, Ibrahim M Elbagory, Alanood S Almurshedi. Controlled-release Carbamazepine matrix granules and tablets comprising lipophillic and hydrophilic components. Drug Del 2009; 16:57–65.
   PubMed Web of Science ®Google Scholar
• Punna Rao Ravi Udaya, Kanth Kotreka, Ranendra Narayan Saha. Controlled Release Matrix Tablets of Zidovudine: Effect of Formulation Variables on the In Vitro Drug Release Kinetics. AAPS PharmSciTech 2008; 9:302–313.
   PubMed Web of Science ®Google Scholar
• Amelia Avachat Vikram, Kotwal. Design and Evaluation of Matrix-Based Controlled Release Tablets of Diclofenac Sodium and Chondroitin Sulphate. AAPS PharmSciTech 2008; 8, Article 88.
   Web of Science ®Google Scholar
• CDER (Centre for Drug Evaluation and Research), Guidance for Industry Extended Release Oral dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations. Food and Drug Administration, Rockville, MD, 1997.
   Google Scholar
• Hidekatsu N, Chiaki H, Tetsuya A, Ichiro O, Yuji M, Susumu N, Kazuhisa T, Yuji K. Application of in vitro dissolution behavior and in vivo plasma concentration profile (IVIVC) for soft gel capsules- a pointless pursuit? Biol Pharm Bull 2007; 30:2221–2225.
   PubMed Web of Science ®Google Scholar
• Bendas ER, Ayres JW. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data. Eur J Pharm Biopharm 2008;69:977–985.
   PubMed Web of Science ®Google Scholar
• Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998;15:698–705.
   PubMed Web of Science ®Google Scholar
• Alistair Burns Roberto, Bernabel, Roger Bullock Alfonso, J Cruz Jentoft, Lutz Frolich Christoph, Hock, Minna Raivio Eric, Triau, Maurits Vandewoude Anders, Wimo, Elizabeth Came Bart, Van Baelen, Gerry L Hammond, Joop C van Oene, Susanne Schwalen. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer’s disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. Lancet Neurol 2009; 8:39–47.
   PubMed Web of Science ®Google Scholar
• Cronin JR. The plant alkaloid galantamine: approved as a drug; sold as a supplement. Alternative and Complementary Therapies 2001; 7(6), 380–383.
   Google Scholar
• Caro VD, Giandalia G, Siragusa1 MG, Campisi G, Giannola LI. Galantamine Delivery on Buccal Mucosa: Permeation Enhancement and Design of Matrix Tablets. JBB 2009; 1:127–134.
   Google Scholar
• Jagadeesh T. R., and Bala Ramesha Chary Development of a novel oral Multi Particulate Drug Delivery System of Galantamine Hydrobromide JPR 2011; 4:77–79.
   Google Scholar
• Khatavkar UN, Shimpi SL, Jayaram Kumar K, Deo KD. Controlled release reservoir mini tablets approach for controlling the release of Galantamine Hydrobromide. Pharm Dev Tech 2011 (Article in press).
   Web of Science ®Google Scholar
• Food and Drug Administration (2001) Drug label: trademark (Galantamine HBr) extended-release capsules. http://www.fda.gov/cder/foi/label/2004/021615lbl.pdf (29 July 2005).
   Google Scholar
• Martindale. Martindale: The Complete Drug Reference. Chicago, IL: Pharmaceutical Press; 2005:1419.
   Google Scholar
• Sutananta W, Craig DQ, Newton JM. An evaluation of the mechanisms of drug release from glyceride bases. J Pharm Pharmacol 1995;47:182–187.
   PubMed Web of Science ®Google Scholar
• Voegele D, Brockmeier D, Von Hattingberg HM, Lippold BC. Mean dissolution time - a parameter for testing release condition comparability. Acta Pharm Technol 1983; 29:167–174.
   Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol 1996; 20:64–74.
   Google Scholar
• Gohel M, Delvadia RR, Parikh DC, Zinzuwadia MM, Soni CD, Sarvaiya KG, Mehta NR, Joshi BR, Dabhi AS. Simplified Mathematical Approach for Back Calculation in Wagner- Nelson Method. Pharmaceutical Reviews 2005; 3:2.
   Google Scholar
• Wagner JG, Nelson E. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug. J Pharm Sci 1964;53:1392–1403.
   PubMed Web of Science ®Google Scholar
• Shiyani B, Gattani S, Surana S. Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech 2008;9:818–827.
   PubMed Web of Science ®Google Scholar
• Vargas CI, Ghaly ES. Kinetic release of theophylline from hydrophilic swellable matrices. Drug Dev Ind Pharm 1999;25:1045–1050.
   PubMed Web of Science ®Google Scholar
• Ford JL, Rubunstein MH, Hogan JE. Propranolol hydrochloride and aminophylline release from matrix tablets containing hydroxypropyl methylcellulose. Int J Pharm 1985; 24:339–350.
   Web of Science ®Google Scholar
• Food and Drug Administration Drug Approval Package: Razadyne (Galantamine Hydrobromide) ER Company: Johnson and Johnson Pharmaceutical Research, Application No. 021615. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021615s000_RazadyneTOC.cfm
   Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49.
   PubMed Web of Science ®Google Scholar
• Wells JI. “Encyclopedia of Pharmaceutical Technology”. Vol. 14, Marcel Dekker, New York, 1997. p. 401–418.
   Google Scholar